Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$650M |
| 2 |
Advanced Micro Devices
AMD
|
+$503M |
| 3 |
Meta Platforms (Facebook)
META
|
+$386M |
| 4 |
Accenture
ACN
|
+$343M |
| 5 |
Cognizant
CTSH
|
+$342M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$895M |
| 2 |
Adobe
ADBE
|
+$597M |
| 3 |
Microsoft
MSFT
|
+$459M |
| 4 |
Apple
AAPL
|
+$449M |
| 5 |
Nike
NKE
|
+$444M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Healthcare | 14.09% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Core Laboratories
CLB
$538M
| $132K | ﹤0.01% |
5,903
-408
| -6% | -$9.23K |
|
1602
Lifestance Health
LFST
$4.16B
| $131K | ﹤0.01% |
14,680
| – | – |
|
1603
B&G Foods
BGS
$285M
| $131K | ﹤0.01% |
+9,110
| New | +$131K |
|
1604
Hope Bancorp
HOPE
$1.72B
| $131K | ﹤0.01% |
15,228
-1,689
| -10% | -$14.7K |
|
1605
FB Financial Corp
FBK
$2.95B
| $130K | ﹤0.01% |
4,519
-277
| -6% | -$7.89K |
|
1606
StoneCo
STNE
$2.62B
| $130K | ﹤0.01% |
10,273
-134
| -1% | -$1.67K |
|
1607
Opko Health
OPK
$921M
| $129K | ﹤0.01% |
60,662
| – | – |
|
|
VBTX
1608
DELISTED
Veritex Holdings
VBTX
| $128K | ﹤0.01% |
6,944
-400
| -5% | -$7.12K |
|
1609
Hawkins
HWKN
$2.91B
| $128K | ﹤0.01% |
2,646
-281
| -10% | -$12.7K |
|
1610
Trupanion
TRUP
$1.05B
| $128K | ﹤0.01% |
6,107
-249
| -4% | -$7.02K |
|
1611
Macy's
M
$6.15B
| $126K | ﹤0.01% |
7,667
-351,235
| -98% | -$5.62M |
|
|
SPTN
1612
DELISTED
SpartanNash
SPTN
| $126K | ﹤0.01% |
5,498
-1,728
| -24% | -$40.5K |
|
1613
Teekay Tankers
TNK
$2.63B
| $126K | ﹤0.01% |
3,291
+1,591
| +94% | +$61.9K |
|
|
CCRN
1614
DELISTED
Cross Country Healthcare
CCRN
| $125K | ﹤0.01% |
4,498
-324
| -7% | -$8.05K |
|
1615
Zentalis Pharmaceuticals
ZNTL
$308M
| $124K | ﹤0.01% |
4,389
| – | – |
|
1616
Metallus
MTUS
$873M
| $124K | ﹤0.01% |
5,616
-552
| -9% | -$9.99K |
|
1617
Arlo Technologies
ARLO
$1.4B
| $123K | ﹤0.01% |
+11,356
| New | +$92.4K |
|
1618
Varex Imaging
VREX
$460M
| $123K | ﹤0.01% |
5,173
-257
| -5% | -$5.35K |
|
|
CCC
1619
CCC Intelligent Solutions
CCC
$3.42B
| $123K | ﹤0.01% |
11,098
| – | – |
|
1620
STAAR Surgical
STAA
$1.16B
| $122K | ﹤0.01% |
2,337
| – | – |
|
1621
Fluence Energy
FLNC
$1.78B
| $120K | ﹤0.01% |
4,604
| – | – |
|
|
BBT
1622
Beacon Financial Corp
BBT
$2.53B
| $120K | ﹤0.01% |
5,679
-448
| -7% | -$9.68K |
|
1623
Customers Bancorp
CUBI
$2.59B
| $119K | ﹤0.01% |
3,832
-72
| -2% | -$1.61K |
|
|
IAS
1624
DELISTED
Integral Ad Science
IAS
| $118K | ﹤0.01% |
6,620
| – | – |
|
1625
Dine Brands
DIN
$432M
| $118K | ﹤0.01% |
2,001
-130
| -6% | -$8.28K |
|
Similar funds
Amundi's Q2 2023 Portfolio in Review
As of Q2 2023, Amundi held 2,165 positions worth $198B, up 6.6% from $186B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Amundi's Q2 2023 filing shows 120 new, 691 increased, 902 reduced and 140 closed positions. Its largest new stake was Clean Harbors: 361,151 shares worth $58.9M. The largest sale was UnitedHealth, an estimated $895M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q2 2023 buy was Clean Harbors: 361,151 shares worth $58.9M.
- Amundi added most to Wells Fargo 7.5% Non Cumv Perp Conv in Q2 2023, an estimated $650M increase.
- Amundi's biggest Q2 2023 reduction was UnitedHealth, cutting an estimated $895M.
- Amundi fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Amundi's ten largest holdings make up 22% of its $198B portfolio in Q2 2023.
- Amundi opened 120 new positions and closed 140 in Q2 2023.
- Amundi's portfolio value rose 6.6% quarter-over-quarter to $198B.
Based on Amundi's 13F filing for Q2 2023, filed 14 Aug 2023.